Egetis Therapeutics AB
$0.6353
7
+$0.00+0% Thursday 20:00
Statistics
Day High
-
Day Low
-
52W High
0.6353
52W Low
0.6353
Volume
-
Avg. Volume
212
Mkt Cap
251.05M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
21AugExpected
Q1 2026
Next
-0.03
-0.02
-0.02
-0.02
Expected EPS
-0.015405
Actual EPS
N/A
Financials
-550.3%Profit Margin
Unprofitable6.58MRevenue
-36.2MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PDPHF. It's not an investment recommendation.
Svenska Handelsbanken AB (publ)
2
SHB-A.ST
Volvo AB
2
VOLV-B.ST
Castellum AB
2
CAST.ST
Skandinaviska Enskilda Banken AB.
2
SEB-A.ST
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Egetis Therapeutics AB (publ), a pharmaceutical company, engages in the development and commercialization of orphan drugs in Sweden and internationally. It develops Aladote, which is in Phase IIb/III clinical trial for the treatment of paracetamol/acetaminophen overdosing and for the prevention of acute liver failure in paracetamol poisoning; and Emcitate, which is in Phase IIb clinical trial for the treatment of monocarboxylate transporter 8 deficiency. The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics AB (publ) was incorporated in 2006 and is headquartered in Stockholm, Sweden.
Show more...
CEO
Country
Sweden
ISIN
SE0003815604
Listings
0 Comments
Share your thoughts
FAQ
What is Egetis Therapeutics AB stock price today?▼
The current price of PDPHF is $0.64 USD — it has increased by +0% in the past 24 hours. Watch Egetis Therapeutics AB stock price performance more closely on the chart.
What is Egetis Therapeutics AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Egetis Therapeutics AB stocks are traded under the ticker PDPHF.
What is Egetis Therapeutics AB market cap?▼
Today Egetis Therapeutics AB has the market capitalization of 251.05M
When is the next Egetis Therapeutics AB earnings date?▼
Egetis Therapeutics AB is going to release the next earnings report on August 21, 2026.
What were Egetis Therapeutics AB earnings last quarter?▼
PDPHF earnings for the last quarter are -0.03 USD per share, whereas the estimation was -0.02 USD resulting in a -26.32% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Egetis Therapeutics AB revenue for the last year?▼
Egetis Therapeutics AB revenue for the last year amounts to 6.58M USD.
What is Egetis Therapeutics AB net income for the last year?▼
PDPHF net income for the last year is -36.2M USD.
In which sector is Egetis Therapeutics AB located?▼
Egetis Therapeutics AB operates in the Other sector.
When did Egetis Therapeutics AB complete a stock split?▼
Egetis Therapeutics AB has not had any recent stock splits.